Clinical Trials Directory

Trials / Unknown

UnknownNCT03558932

IP3R Modulation by Cancer Genes in Mesothelioma

IP3R Modulation by Cancer Genes Bcl-2 & PKM2 in Mesothelioma

Status
Unknown
Phase
—
Study type
Observational
Enrollment
20 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Obtaining pleural biopsies in cases of malignant mesothelioma to detect molecular mechnisms and signal transduction

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTpleural biopsydiagnostic sampling

Timeline

Start date
2019-01-01
Primary completion
2023-12-01
Completion
2024-06-01
First posted
2018-06-15
Last updated
2018-06-15

Source: ClinicalTrials.gov record NCT03558932. Inclusion in this directory is not an endorsement.

IP3R Modulation by Cancer Genes in Mesothelioma (NCT03558932) · Clinical Trials Directory